Lineage Cell Therapeutics, Inc. (LCTX) earnings
LCTX earnings moved a median of -0.48% by the close. Quarterly and annual LCTX reports and results, each read against the price at its own news timestamp. Back to the LCTX overview →
18 measured LCTX earnings events.
Where these LCTX earnings landedvs 18 measured LCTX earnings reactions
| Middle 50% of LCTX earnings reactions | -2.35% to +1.74% |
|---|---|
| Median reaction (to close) | -0.48% |
| Measured reactions | 18 |
Point-in-time · zero look-ahead
Half of the 18 LCTX earnings events with a measured close landed between -2.35% and +1.74%; 39% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update | Press release | +2.27% | +0.00% | |
| Lineage Cell Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 6, 2026 | Press release | -0.09% | +4.72% | |
| Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update | Press release | -4.85% | -4.48% | |
| Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026 | Press release | +1.03% | +0.00% | |
| Lineage Cell Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update | Press release | +4.14% | +12.10% | |
| Lineage Cell Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025 | Press release | +0.60% | +10.18% | |
| Lineage Cell Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update | Press release | +2.06% | +6.19% | |
| Lineage Cell Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update on August 12, 2025 | Press release | +0.85% | -1.41% | |
| Lineage Cell Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update | Press release | +0.77% | -2.55% | |
| Lineage Cell Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update on May 13, 2025 | Press release | -4.12% | +1.74% | |
| Lineage Cell Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update | Press release | +0.03% | -7.70% | |
| Lineage Cell Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update on November 14, 2024 | Press release | +2.77% | +0.57% | |
| Lineage Cell Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update | Press release | +1.76% | -1.23% | |
| Lineage Cell Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024 | Press release | +0.00% | -6.40% | |
| Lineage Cell Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update | Press release | +2.61% | +1.74% | |
| Lineage Cell Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024 | Press release | -2.68% | -6.25% | |
| Lineage Cell Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update | Press release | +2.86% | -0.95% | |
| Lineage Cell Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on November 9, 2023 | Press release | -1.75% | -1.75% |
Keep exploring
More LCTX: analyst actions → · SEC filings → · LCTX overview →